HIV and reproduction

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 3, 2004, Pages 257-262

  Semprini, Augusto E ^a,b,c   Fiore, Simona ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NONE   (Italy)

Author keywords

HIV; Insemination; Intracytoplasmatic sperm injection (ICSI); IVF; Reproduction

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTIFICIAL INSEMINATION; BREAST FEEDING; CESAREAN SECTION; CLINICAL TRIAL; CONCEPTION; DRUG EFFICACY; ELECTIVE SURGERY; EMBRYOTOXICITY; FERTILIZATION; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INFERTILITY THERAPY; LIFE EXPECTANCY; MATERNAL MORBIDITY; MEDICAL TECHNOLOGY; MOTHER; PATIENT COUNSELING; POSTNATAL CARE; PREGNANCY; PRIORITY JOURNAL; PROTECTION; REPRODUCTION; REVIEW; RISK REDUCTION; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SPERM; SPERMATOZOON; TOXICITY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION;

FEMALE; FERTILIZATION IN VITRO; HIV INFECTIONS; HUMANS; INFERTILITY, FEMALE; MALE; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 2542533732     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200406000-00009     Document Type: Review

References (39)

1. Klein J, Pena JE, Thornton MH, Sauer MV. Understanding the motivations, concerns, and desires of human immunodeficiency virus1-serodiscordant couples wishing to have children through assisted reproduction. Obstet Gynecol 2003; 101 (5 Pt 1):987-994.
2. Mocroft A, Ledergerber B, Katlama C, et al. EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-29.
3. Anderson DJ. Assisted reproduction for couples infected with the human immunodeficiency virus type 1. Fertil Steril 1999; 72:592-594.
4. Gilling-Smith C, Smith JR, Semprini AE. HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive. BMJ 2001; 322:566-567.
5. Sharma S, Gilling-Smith C, Semprini AE, et al. Assisted conception in couples with HIV infection. Sex Transm Infect 2003; 79:185-188.
6. Savasi V, Lanzani C, Persico T, et al. Pregnancy by self-insemination in women infected by HIV-1 [abstract]. In: Abstracts Book of the 57th Annual Meeting of the American Society for Reproductive Medicine; 2001. p. 349. Orlando, Florida, USA, 20-25 October, 2001.
7. Mandelbrot L, Heard I, Henrion-Geant E, Henrion R. Natural conception in HIV-negative women with HIV-infected partners. Lancet 1997; 349:850-851.
8. Vernazza PL, Gilliam BL, Flepp M, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997; 11:1249-1254.
9. Dunne AL, Mitchell F, Allen KM, et al. Analysis of HIV-1 viral load in seminal plasma samples. J Clin Virol 2003; 26:239-245.
10. Chakraborty H, Sen PK, Helms RW, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001; 15:641-643.
11. Semprini AE, Fiore S, Pardi G. Reproductive counselling for HIV-discordant couples. Lancet 1997; 349:1401-1402.
12. Semprini AE, Vucetich A, Morandi E, et al. Removal of p18 immunoreactive cells from the semen of HTLV-III LAV seropositive men. Colloque INSERM 1987; 154:462.
13. Semprini AE, Levi-Setti PE, Bozzo M, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992; 340:1317-1319.
14. Semprini AE, Levi-Setti PE, Oneta M, et al. Insemination of HIV-seronegative women with processed semen of HIV-seropositive men: an update. AIDS Read 1993; 3:184-190.
15. Anderson DJ, Politch JA, Oneta M, et al. Efficacy of conventional semen processing techniques in separation of motile sperm from HIV-1 and HIV-1 host cells [abstract]. In: Abstracts Book of the 48th Annual Meeting of the American Fertility Society; 1992; p. 107. New Orleans, Louisiana, USA 2-5 November, 1992
16. Taylor S, Sadiq ST, Weller I. Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections. Antivir Therap 2003; 8:479-483.
17. Semprini AE, Persico T, Thiers V, et al. Absence of hepatitis C virus and detection of HGV/GBV-C RNA sequences in the semen of infected men. J Infect Dis 1998; 177:848-854.
18. Pasquier C, Bujan L, Daudin M, et al. Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol 2003; 69:344-349.
19. Semprini AE, Vucetich A, Oneta M, et al. Sperm washing and ICSI for men with HIV infection wishing for a child. In: Abstracts Book of 57th Annual Meeting of the American Society for Reproductive Medicine; 2001; p. 403. Orlando, Florida, USA, 20-25 October, 2001
20. Law MG, Downs AM, Brunet JB, Kaldor JM. Time trends in HIV infection among pregnant women in Europe. AIDS 1999; 12:211-216.
21. Cazein F, Hamers FF, Brunet JB. HIV prevalence in pregnant women in Europe: differences in assessment methods and prevalence levels across countries. J Acquir Immune Def Syndr Hum Retrovirol 1998; 19:296-305.
22. Connor EM, Sperling RS, Gelic R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331:1173-1180.
23. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999; 353:773-780.
24. Guay L, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795.
25. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339:1409-1414.
26. Food and Drug Administration. FDA/Bristol Myers Squibb issues caution for HIV combination therapy with Zerit and Videx in pregnant women. Rockville: Department of Health and Human Services; 2001.
27. Dube MP, Sattler F. Metabolic complications of antiretroviral therapies. AIDS Clin Care 1998; 10:41-44.
28. Thorne C, Fiore S, Rudin C. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2003; 348:471-472. The use of antiretrovirals can reduce viral replication and disease progression in individuals infected with HIV.
29. European Collaborative Study. Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br J Obstet Gynaecol 1998; 105:704-709.
30. The International Perinatal HIV group. Mode of delivery and vertical transmission of HIV-1: A meta-analysis from fifteen prospective cohort studies. N Engl J Med 1999; 340:977-987.
31. European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353:1035-1039.
32. Semprini AE, Castagna C, Ravizza M, et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 1995; 9:913-917.
33. Fiore S, Newell M-L, Thorne C, et al. A higher incidence of post-partum complications in HIV infected than uninfected women irrespective of mode of delivery. AIDS (in press).
34. loannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type-1 by pregnant women with RNA virus loads <1000 copies/ml. J Infect Dis 2001; 183:539-545.
35. Coll O, Fiore S, Floridia M, et al. Pregnancy and HIV infection: A European consensus on management. AIDS 2002; 16 (Suppl 2):S1-S18.
36. American College of Obstetricians and Gynecologists. Scheduled caesarean delivery and the prevention of vertical transmission of HIV infection. ACOG Committee Opinion number 234. Washington D.C.: American College of Obstetricians and Gynecologists; 2000.
37. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al. Ghent IAS Working Group on HIV in Women Children. Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr. 2004; 35:196-202.
38. Coutsoudis A, Pillay K, Spooner E, et al. For the South African Vitamin A Study Group. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. AIDS 1999; 13:1517-1524.
39. Taha TE, Biggar RJ, Broadhead RL, et al. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997; 315:216-219.